Sands Capital Ventures »

Alamar Biosciences shares owned by Sands Capital Ventures

Quarter-by-quarter ownership of Alamar Biosciences shares owned by Sands Capital Ventures from 13F filings

Historical chart of Sands Capital Ventures investment in Alamar Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Alamar Biosciences held by Sands Capital Ventures consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alamar Biosciences by Sands Capital Ventures

Quarter filed Position value Share count Share price at filing
2026-06-30 $115M 4.2M 27.09

More positions owned by Sands Capital Ventures

Alamar Biosciences Common Stock
Nu Hldgs Ord Shs Cl A (NU)
Klaviyo Com Ser A (KVYO)
Beta Bionics (BBNX)
Spyglass Pharma Com Shs (SGP)
Inhibikase Therapeutics Com New (IKT)
Doordash Cl A (DASH)
Coupang Cl A (CPNG)
Datadog Cl A Com (DDOG)
Bioage Labs (BIOA)
10x Genomics Cl A Com (TXG)
Samsara Com Cl A (IOT)
Odyssey Therapeutics Common Stock
Toast Cl A (TOST)
Acumen Pharmaceuticals (ABOS)

View all positions for Sands Capital Ventures

Top funds holding Alamar Biosciences

Sands Capital Ventures
Samsara BioCapital
ARK Investment Management
Braidwell
Alliancebernstein
Hillhouse Capital Advisors
Millennium Management
FMR
Pura Vida Investments
Emerald Advisers
Artisan Partners Limited Partnership
Deerfield Management Company
Vanguard Capital Management
Farallon Capital Management
Wellington Management Company

View all funds holding Alamar Biosciences